Joyce Nakatumba‐Nabende
Biographic Data
| ID | 9120459 |
|---|---|
| NAME | Joyce Nakatumba‐Nabende |
| GIVEN NAMES | Joyce |
| FAMILY NAME | Nakatumba‐Nabende |
| SIGNATURE | NABENDE J N |
| AFFILIATIONS | Makerere University |
| ORCID | 0000-0002-0108-3798 |
| VERIFIED | Yes |
| TOTAL WORKS | 4 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 4 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2024 |
| LATEST PUBLICATION YEAR | 2026 |
| H-INDEX | 0 |
Durable viral suppression in the dolutegravir era
Despite widespread rollout of dolutegravir-based (DTG) antiretroviral therapy (ART) in East Africa, viral non-suppression, advanced HIV disease (AHD), and multimorbidity persist, reflecting gaps in service response rather than regimen potency alone. In Uganda’s The AIDS Support Organization (TASO) routine-care cohort (2014–2024; n = 54,348 people living with HIV), integrase inhibitor uptake is near universal, yet AHD remains common, and tuberculo…
Decade-long antiretroviral therapy in Uganda
The scale-up of antiretroviral therapy (ART) has transformed the HIV epidemic in sub-Saharan Africa, yet longitudinal public health insights from national programmatic cohorts remain scarce. As global targets move toward epidemic control and elimination of virological failure, understanding how profiles and outcomes of people living with HIV (PLWH) evolve in real-world settings is essential. The AIDS Support Organisation (TASO), Uganda’s largest …
Data science without borders
Background: Effective public health data science in Africa requires a comprehensive understanding of institutional capabilities across multiple dimensions. This study conducted a multidimensional assessment of three African health institutions to examine the availability of health data, healthcare training, data governance needs, and infrastructure capabilities, to inform the use of data science tools to address health challenges. Methods: The st…
Barriers to global engagement for African researchers
African researchers continue to face numerous barriers that limit the global dissemination and advancement of their research. These include high open-access publication fees, requirements for publishing in high-impact journals, inability to attend or host international conferences, and limited access to published papers and resources. In this viewpoint, we focus on the specific challenge of attending [...]
No prominent works on this page.
Barriers to global engagement for African researchers
African researchers continue to face numerous barriers that limit the global dissemination and advancement of their research. These include high open-access publication fees, requirements for publishing in high-impact journals, inability to attend or host international conferences, and limited access to published papers and resources. In this viewpoint, we focus on the specific challenge of attending [...]
Data science without borders
Background: Effective public health data science in Africa requires a comprehensive understanding of institutional capabilities across multiple dimensions. This study conducted a multidimensional assessment of three African health institutions to examine the availability of health data, healthcare training, data governance needs, and infrastructure capabilities, to inform the use of data science tools to address health challenges. Methods: The st…
Durable viral suppression in the dolutegravir era
Despite widespread rollout of dolutegravir-based (DTG) antiretroviral therapy (ART) in East Africa, viral non-suppression, advanced HIV disease (AHD), and multimorbidity persist, reflecting gaps in service response rather than regimen potency alone. In Uganda’s The AIDS Support Organization (TASO) routine-care cohort (2014–2024; n = 54,348 people living with HIV), integrase inhibitor uptake is near universal, yet AHD remains common, and tuberculo…
Decade-long antiretroviral therapy in Uganda
The scale-up of antiretroviral therapy (ART) has transformed the HIV epidemic in sub-Saharan Africa, yet longitudinal public health insights from national programmatic cohorts remain scarce. As global targets move toward epidemic control and elimination of virological failure, understanding how profiles and outcomes of people living with HIV (PLWH) evolve in real-world settings is essential. The AIDS Support Organisation (TASO), Uganda’s largest …
Cohort (2 works) · Global Health and Surgery (2 works) · HIV-related health complications and treatments (2 works) · HIV/AIDS drug development and treatment (2 works) · HIV/AIDS Research and Interventions (2 works) · Public health (2 works) · Socioeconomic status (2 works) · Alliance (1 work) · Antiretroviral therapy (1 work) · Artificial Intelligence in Healthcare and Education (1 work)